Article

Oncologist Beth Overmoyer on Inflammatory Breast Cancer

Beth Overmoyer, a breast oncologist at the Susan F. Smith Center for Women's Cancer's at Dana-Farber in Boston, provides a brief overview of inflammatory breast cancer.

Beth Overmoyer, a breast oncologist at the Susan F. Smith Center for Women’s Cancer’s at Dana-Farber in Boston, provides a brief overview of women likely to be diagnosed with inflammatory breast cancer, and the need for a better understanding of the disease.

Inflammatory breast cancer is found in both premenopausal and postmenopausal women. Overmoyer says the biology of inflammatory breast cancer differs from other types of breast cancer. Clinical presentations of the disease are often missed by both practitioners and patients. A poster session at the 2014 San Antonio Breast Cancer Symposium provided attendees with the opportunity to explore inflammatory breast cancer, its epidemiology and its outcomes.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Image of man.